期刊文献+

复发-缓解型多发性硬化症相关的全身和中枢神经系统细胞免疫差异

Differences in systemic and central nervous system cellular immunity relevant to relapsing-remitting multiple sclerosis
下载PDF
导出
摘要 In order to elucidate the differences between systemic and central nervous system (CNS) immunity that are relevant to exacerbations of multiple sclerosis (MS), paired peripheral blood and cerebrospinal fluid (CSF) samples obtained from 36 nontreated patients with relapsing-remitting MS (RRMS) were simultaneously examined using flow cytometry to determine the percentages of functional lymphocyte subsets, as well as enzyme-linked immunosorbent assays for measu- ring soluble immune mediators.Active RRMS patients (n = 27) were characterized by an increase in CD4+CXCR3+Th1 cells in blood as compared with inactive patients (n = 9), and this parameter was inversely correlated with plasma levels of IL-10 and IL-12p70. In contrast, an increase in the percentage of CD4+CD25+cells and a decrease in the percentage of CD8+CD11ahigh cells were features of CSF samples from those with active RRMS. Further, CSF CD4+CD25+cells had a close association with leukocyte counts as well as albumin and CXCL10 levels in the CSF, and, thus, could be useful as a measure for inflammatory reactions in the CNS. On the other hand, CD8+CD11ahigh cells may function as immunoregulatory cells, as their percentage in the CSF showed a positive correlation with CSF levels of the anti-inflammatory cytokine IL-4. These findings suggest that MS relapses occur in a combination with altered cell-mediated immunity that differs between the peripheral blood and CSF compartments, while measurement of lymphocyte subsets may be helpful for monitoring disease status. In order to elucidate the differences between systemic and central nervous system (CNS) immunity that are relevant to exacerbations of multiple sclerosis (MS), paired peripheral blood and cerebrospinal fluid (CSF) samples obtained from 36 nontreated patients with relapsing-remitting MS (RRMS) were simultaneously examined using flow cytometry to determine the percentages of functional lymphocyte subsets, as well as enzyme-linked immunosorbent assays for measu- ring soluble immune mediators.Active RRMS patients (n = 27) were characterized by an increase in CD4+CXCR3+Th1 cells in blood as compared with inactive patients (n = 9), and this parameter was inversely correlated with plasma levels of IL-10 and IL-12p70. In contrast, an increase in the percentage of CD4+CD25+cells and a decrease in the percentage of CD8+CD11ahigh cells were features of CSF samples from those with active RRMS. Further, CSF CD4+CD25+cells had a close association with leukocyte counts as well as albumin and CXCL10 levels in the CSF, and, thus, could be useful as a measure for inflammatory reactions in the CNS. On the other hand, CD8+CD11ahigh cells may function as immunoregulatory cells, as their percentage in the CSF showed a positive correlation with CSF levels of the anti-inflammatory cytokine IL-4. These findings suggest that MS relapses occur in a combination with altered cell-mediated immunity that differs between the peripheral blood and CSF compartments, while measurement of lymphocyte subsets may be helpful for monitoring disease status.
机构地区 Dr.Dept. of Neurology
出处 《世界核心医学期刊文摘(神经病学分册)》 2005年第12期31-32,共2页 Digest of the World Core Medical Journals:Clinical Neurology
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部